NRSN icon

NeuroSense Therapeutics
NRSN

Overview Fund Trends Analyst Outlook Journalist POV

5 hedge funds and large institutions have $380K invested in NeuroSense Therapeutics in 2021 Q4 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
5
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$184K
2
+$135K
3
+$38K
4
UBS Group
UBS Group
Switzerland
+$20K
5
TRCT
Tower Research Capital (TRC)
New York
+$3K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$184K
2
$135K
3
$38K
4
$20K
5
$3K